Humacyte, Inc.

NASDAQ:HUMA

Biotechnology

Healthcare
$0.50 -3.35%

-$0.03 today

Market cap
$139.18M
Beta
2.46
P/E (TTM)
-1.9
EPS (TTM)
-$0.49
52W Low $0.55High $2.84

Volume 4.34M

Average 8.14M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$105.04M

FY 2025 · Annual

Investing Cash Flow

-$884,000.00

FY 2025 · Annual

Financing Cash Flow

$61.49M

FY 2025 · Annual

-46.2% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(26.48M)(11.97M)(110.78M)(148.7M)(40.83M)
Depreciation & Amortization8.24M8.21M7.72M7.19M5.33M
Deferred Income Tax00000
Stock-Based Compensation10.15M6.18M6.83M6.14M9.75M
Change in Working Capital(557K)1.03M6.57M311K(23.4M)
Accounts Receivables(63K)145K31K0(261K)
Inventory0000(21.83M)
Accounts Payables(197K)(509K)4.81M(1.96M)973K
Other Working Capital(297K)1.39M1.73M2.27M(2.28M)
Other Non-Cash Items(72.54M)(74.59M)16.35M36.94M(55.9M)
Operating Cash Flow(81.19M)(71.13M)(73.31M)(98.12M)(105.04M)
Capital Expenditures(220K)(1.05M)(2.28M)(1.57M)(884K)
Acquisitions (Net)00000
Purchases of Investments(8M)(10.11M)000
Sales of Investments016M2.11M00
Other Investing Activities00000
Investing Cash Flow(8.22M)4.85M(173K)(1.57M)(884K)
Debt Repayment27.93M(1.98M)5.7M(2.58M)36.39M
Common Stock Issued598K535K566K45.93M113.44M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities239.05M535K(1.76M)27.71M(88.34M)
Financing Cash Flow266.98M(1.45M)4.51M114.18M61.49M
Effect of Forex Changes00(209K)00
Net Change in Cash177.57M(67.73M)(69.18M)14.49M(44.44M)
Free Cash Flow(81.41M)(72.18M)(75.59M)(99.69M)(105.93M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$40.8M
+ D&A$5.3M
+ Stock-Based Comp$9.8M
+ Deferred Tax$0
- Working Capital-$23.4M
- Other Non-Cash-$55.9M
= Operating Cash Flow-$105.0M
- Capex-$884.0K
= Free Cash Flow-$105.9M

Analysis

FY2025 free cash flow is -$105.9M. FCF conversion is 259.4% of net income. Operating cash flow was -$105.0M, with capex of -$884.0K. The largest bridge item is Other Non-Cash at -$55.9M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 10, 2026
8-KCurrent reportNov 10, 2026
4Statement of changes in beneficial ownershipOct 7, 2026
4Statement of changes in beneficial ownershipOct 7, 2026
3Initial statement of beneficial ownershipSep 28, 2026

Does HUMA generate free cash flow?

Humacyte, Inc. (HUMA) generated -$105.93M of free cash flow in fiscal 2025.

How much operating cash flow does HUMA produce?

Operating cash flow was -$105.04M, before capital expenditures of $884,000.00.